Avi Loeb, a distinguished cosmologist who previously led Harvard’s astronomy department until 2020 and conducted extensive research on black holes, was recently appointed to chair a new scientific ...
NAD+ levels fall up to 65% as we age. Learn the clinical science behind Niagen Bioscience's NAD precursor and how it fights ...
Some people leave college with a degree. Mark Zuckerberg left with a startup idea, a near-expulsion story and the woman he ...
Discover the science of NAD+ and how it impacts your healthspan. Watch Mona Rosene explain cellular repair and how to fight ...
Satellos Bioscience's shares jumped Monday after the Duchenne treatment being developed by the biotechnology company received fast track designation in the U.S. In morning trading, the shares rose 12% ...
As America approaches its 250th anniversary, the companies will pursue the development of scalable seedling technologies to support the first-ever restoration of a native tree species from functional ...
SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ("Duchenne" or "DMD")Fast Track is designed to expedite the development/re ...
SAT-3247 has now received FDA Fast Track, Orphan Drug and Rare Pediatric Disease designations for Duchenne muscular dystrophy ('Duchenne” or 'DMD”)Fast Track is designed to expedite the ...
Connecticut bioscience expert admits initial skepticism about Philip Morris' plan to 'end sale of cigarettes.' Now he cites ...
Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“Satellos” or the “Company”), a clinical-stage biotechnology company ...
First consumer health product positions Daré for revenue generation while expanding its women's health leadership platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results